Structure-based organic synthesis of drug prototypes: A personal odyssey

ChemMedChem

Volumn 1, Issue 12, 2006, Pages 1300-1330

  Hanessian, Stephen ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Medicinal chemistry; Natural products; Synthesis

Indexed keywords

EID: 33846211453     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200600203     Document Type: Review

References (500)

1. a) K. C. Nicolaou, D. Vourloumis, N. Winssinger, P. S. Baran, Angew. Chem. 2000, 112, 46;
2. Angew. Chem. Int. Ed. 2000, 39, 44;
3. b) K. C. Nicolaou, E. J. Sorensen, Classics in Total Synthesis II, Wiley-VCH, Weinheim, 2003;
4. c) K. C. Nicolaou, E. J. Sorensen, Classics in Total Synthesis, VCH, Weinheim, 1996;
5. d) E. J. Corey, S.-M. Cheng, The Logic of Chemical Synthesis, Wiley, New York, 1989.
6. a) R. B. Woodward in Perspectives in Organic Synthesis (Ed.: A. R. Todd), Interscience, New York, 1956;
7. b) E. J. Corey, Chemist (Washington, DC), July/August, 1989, p. 3.
8. For example, see: a) Science of Synthesis, Vol. 1-10, Thieme, New York, 2006;
9. b) L. Kürti, B. Czako, Strategic Applications of Named Reactions in Organic Synthesis, Elsevier, Amsterdam, 2005;
10. c) Comprehensive Organic Functional Group Transformations, Vol. 1-6 (Eds.: A. R. Katritsky, R. J. K. Taylor), Elsevier, Amsterdam, 2005;
11. d) Handbook of Reagents for Organic Synthesis (Ed.: L. A. Paquette), Wiley, New York, 1993;
12. e) Comprehensive Organic Synthesis, Vol. 1-9 (Eds.: B. M. Trost, I. Fleming), Pergamon, New York, 1991;
13. f) D. Seebach, Angew. Chem. 1990, 102, 1363;
14. Angew. Chem. Int. Ed. Engl. 1990, 29, 1320.
15. a) F. E. Koehn, G. T. Center, Nat. Rev. Drug Discovery 2005, 4, 206;
16. b) Anticancer Agents from Natural Products (Eds.: G. M. Cragg, D. G. I. Kingston, D. J. Newman), CRC Press/Taylor & Francis Group, Boca Raton, FL, 2005;
17. c) Natural Products - Drug Discovery and Therapeutic Medicine (Eds.: L. Zhang, A. L. Demain), Humana Press, Totowa, 2005;
18. d) D. J. Newman, G. M. Cragg, Curr. Med. Chem. 2004, 11, 1693;
19. e) J. Clardy, C. Walsh, Nature 2004, 432, 829;
20. f) P. Vuorela, M. Leinonen, P. Saikku, P. Tammela, J.-P. Rauha, T. Wenneberg, H. Vuorela Curr. Med. Chem. 2004, 11, 1375;
21. g) A. M. Rouhi, Chem. Eng. News 2003, 81 (October 13), 77;
22. h) Comprehensive Natural Products Chemistry, Vol. 1-9 (Eds.: D. H. R. Barton, K. Nakanishi, O. Meth-Cohn), Pergamon, New York, 1999.
23. a) B. R. Stockwell, Nature 2004, 432, 846;
24. b) M. MacCoss, T. A. Baillie, Science 2004, 303, 1810.
25. Human Genome Special Issue: Science 2001, 291, 1145.
26. G. Schneider, U. Fechner, Nat. Rev. Drug Discovery 2005, 4, 649.
27. S. Hanessian in Chemical Synthesis (Eds.: C. Chatglialoglu, V. Snieckus), Kluwer Academic, Netherlands, 1996, p. 61.
28. M. A. Sierra, M. C. de La Torre, Dead Ends and Detours - Direct Ways to Successful Total Synthesis, Wiley-VCH, Weinheim, 2006.
29. S. Hanessian, Curr. Opin. Drug Discovery Dev. 2005, 8, 798.
30. Protein Crystallography in Drug Discovery (Eds.: R. E. Babine, S. S. Abdel-Meguid), Wiley-VCH, Weinheim, 2004.
31. For authoritative monographs, see: a) Comprehensive Asymmetric Catalysis (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, Heidelberg, 1996;
32. nd ed., 2000;
33. c) For asymmetry with relevance to the pharmaceutical industry, see: H. J. Federsel, Nat. Rev. Drug Discovery 2005, 4, 685;
34. d) Asymmetric Catalysis on Industrial Scale (Eds.: H. U. Blaser, E. Schmidt), Wiley-VCH, Weinheim, 2004;
35. e) H. Y. Aboul-Enein, I. G. Wainer, The Impact of Stereochemistry on Drug Development and Use, Wiley, New York, 1997.
36. C. Lipinski, A. Hopkins, Nature 2004, 432, 855.
37. E. J. Corey, Pure Appl. Chem. 1967, 14, 19.
38. S. Hanessian, J. Franco, B. Larouche, Pure Appl. Chem. 1990, 62, 1887.
39. a) Exploiting Chemical Diversity for Drug Discovery (Eds.: P. A. Bartlett, M. Enzeroth,), RSC Publisher, UK, 2006;
40. b) D. P. Walsh, Y.-T. Chang, Chem. Rev. 2006, 106, 2476;
41. c) M. D. Burke, E. M. Berger, S. L. Schreiber, Science 2003, 302, 613;
42. d) S. L. Schreiber, Science 2000, 287, 1964.
43. a) L. Weber, Curr. Med. Chem. 2002, 9, 2085;
44. b) R. Breinbauer, I. R. Vetter, H. Waldman, Angew. Chem. 2002, 114, 3002;
45. Angew. Chem. Int. Ed. 2002, 41, 2878;
46. c) P. Arya, R. Joseph, D. T. H. Chou, Chem. Biol. 2002, 9, 145;
47. d) H. E. Relisn, N. J. Westwood, Y. Feng, T. Kirchauser, M. D. Shair, J. Am. Chem. Soc. 2001, 123, 6740.
48. "Combinatorial Chemistry: From Theory to Application": a) Methods and Principles in Medicinal Chemistry, Vol. 26 (Eds.: W. Bannwarth, B. Hinzen), Wiley-VCH, Weinheim, 2006;
49. b) M. C. Pirrung, Molecular Diversity and Combinational Chemistry - Principles and Applications, Elsevier, Oxford, UK, 2004 (Tetrahedron Organic Series).
50. a) J. Mervis, Science 2005, 309, 721;
51. b) R. Breinbauer, M. Manger, M. Scheck, H. Waldman, Curr. Med. Chem. 2002, 9, 2129.
52. P. A. Wender, J. S. Baryza, S. E. Bremer, M. O. Clarke, M. L. Craske, J. C. Horan, T. Meyer, Curr. Drug Discovery Technol. 2004, 1, 1.
53. K. C. Nicolaou, F. Roschangar, D. Vourloumis, Angew. Chem. 1998, 110, 2120;
54. Angew. Chem. Int. Ed. 1998, 37, 2014.
55. A. Rivkin, F. Yoshimura, A. E. Gabarda, T.-C. Chou; H. Dong, W. P. Tong, S. J. Danishefsky, J. Am. Chem. Soc. 2003, 125, 2899.
56. a) U. Klar, B. Buchmann, W. Schwede, W. Skuballa, J. Hoffmann, R. B. Lichter, Angew. Chem. 2006, DOI: 10.1002/ange.200602785;
57. Angew. Chem. Int. Ed. 2006, DOI: 10.1002/anie.200602785;
58. b) K.-H. Altmann, Mini-Rev. Med. Chem. 2003, 3, 149;
59. c) M. Wartman, K.-H. Altmann, Anticancer Agents 2002, 2, 123.
60. For example, see: a) Structure-based Discovery - An Overview (Ed.: R. F. Hubbard), RSC Publishing, London, 2006;
61. b) Analogue-based Drug Discovery (Eds.: J. Fischer, C. R. Ganellin), Wiley-VCH, Weinheim, 2005;
62. c) K. A. Thiel, Nat. Biotechnol. 2004, 22, 513;
63. d) A. C. Anderson, Chem. Biol. 2003, 10, 787;
64. e) G. Klebe, J. Mol. Med. 2000, 78, 269;
65. f) H. Kubinyi, Curr. Opin. Drug Discovery Dev. 1998, 1, 4;
66. g) R. S. Bohacek, C. McMartin, W. C. Guida, Med. Res. Rev. 1996, 16, 3;
67. h) P. J. Whittle, T. L. Blundell, Annu. Rev. Biophys. Biomol. Struct. 1994, 23, 349;
68. i) M. D. Walkinshaw, Med. Res. Rev. 1992, 12, 317;
69. j) For an academic perspective, see: F. Hof, F. Diederich, Chem. Commun. 2004, 477.
70. D. C. Rees, M. Congreve, C. W. Murray, R. Can, Nat. Rev. Drug Discovery 2004, 3, 660.
71. D. A. Erlanson, R. S. McDowell, T. O'Brien, J. Med. Chem. 2004, 47, 3463.
72. a) S. B. Shuker, P. J. Hajduk, R. P. Meadows, S. W. Fesik, Science 1996, 274, 1531;
73. b) J. Fejzo, C. A. Lepre, J. W. Peng, G. W. Bemis, Ajay, M. A. Murcko, J. M. Moore, Chem. Biol. 1999, 6, 755.
74. M. Pellechia, D. S. Sem, K. Wüthrich, Nat. Rev. Drug Discovery 2002, 1, 211.
75. V. L. Nienaber, P. L. Richardson, V. Klighofer, J. J. Bouska, V. L. Giranda, J. Greer, Nat. Biotechnol. 2000, 18, 1105.
76. a) A. Sharff, H. Jhoti, Curr. Opin. Chem. Biol. 2003, 7, 340;
77. b) L. Blundell, H. Jhoti, C. Abell, Nat. Rev. Drug Discovery 2002, 1, 45.
78. S. A. Hofstadler, R. H. Griffey, Curr. Opin. Drug. Discov. Dev. 2000, 3, 423.
79. a) H. J. Böhm, G. Klebe, Angew. Chem. 1996, 108, 2750;
80. Angew. Chem. Int. Ed. Engl. 1996, 35, 2588;
81. b) K. Müller in Perspectives in Drug Discovery and Design (Eds.: P. S. Anderson, G. L. Kenyon, G. R. Marshall), ESCOM, Leiden, 1995;
82. c) H. Kubinyi, Curr. Opin. Drug Discovery Dev. 1998, 1, 4;
83. d) J. H. Van Drie, M. S. Lajiness, Drug Discovery Today 1998, 3, 274;
84. e) W. P. Walters, M. T. Stahl, M. A. Murcko, Drug Discovery Today 1998, 3, 160.
85. a) W. Cabri, R. Difabio, From Bench to Market - The Evolution of Chemical Synthesis, Oxford University Press, Oxford, UK, 2000;
86. b) Process Chemistry in the Pharmaceutical Industry (Ed.: K. G. Gadamasetti), Dekker, New York, 1999;
87. for a recent thematic issue, see: M. F. Lipton, A. G. M. Barrett (Guest Eds.), Chem. Rev. 2006, 106, 2581.
88. a) J. D. A. Tyndall, T. Nall, D. P. Fairlie, Chem. Rev. 2005, 105, 973;
89. b) W. A. Loughlin, J. D. A. Tyndall, M. P. Glenn, D. P. Fairlie, Chem. Rev. 2004, 104, 6085;
90. c) M. N. Greco, B. F. Maryanoff, Adv. Amino Acid Mimetics and Peptidomimetics, Vol. 1, JAI, London, 2002, p. 41;
91. d) R. E. Babine, S. L. Bender, Chem. Rev. 1997, 97, 1359.
92. For example, see: a) H. F. Noller, Science 2005, 309, 1508;
93. nd ed., Cold Spring Harbor Laboratory Press, New York, 1999;
94. c) E. Cundliffe in The Ribosome Structure, Function and Evolution (Eds.: W. E. Hill, et al.), American Chemical Society for Microbiology, Washington, DC, 1990, p. 479.
95. a) J. M. Ogle, V. Ramakrishnan, Annu. Rev. Biochem. 2005, 74, 129, and references therein;
96. b) B. T. Winberley, D. E. Brodersen, J. W. M. Clemons, R. J. Morgan-Warren, A. P. Caster, C. Vonrhein, T. Hartsek, V. Ramakrishnan, Nature 2000, 407, 327.
97. For example, see: a) E. F. Gale, E. Cundliffe, P. E. Reynolds, M. H. Richmond, M. J. Waring, The Molecular Basis of Antibiotic Action, Wiley, London, 1981;
98. b) H. F. Noller, Annu. Rev. Biochem. 1991, 60, 91;
99. c) R. C. Goldman, S. W. Fesik, C. C. Doran, Antimicrob. Agents Chemother. 1990, 34, 426, and references therein.
100. a) J. L. Hansen, P. B. Moore, T. A. Steitz, J. Mol. Biol. 2003, 330, 10611;
101. b) F. Schlunzen, J. Harus, A. Tocilj, R. Albrecht, A. Yonath, F. Franceschi, Nature 2001, 413, 814;
102. c) S. Kirillov, B. T. Porse, B. Vester, P. Wolley, R. Garett, FEBS Lett. 1997, 406, 223.
103. A. P. Carter, D. E. Clemons, R. J. Brodersen, R. J. Morgan-Warren, B. T. Wimberley, V. Ramakrishnan, Nature 2000, 407, 340.
104. a) B. François, R. J. M. Russell, J. B. Murray, F. Aboul-ela, B. Masquida, Q. Vicens, E. Westhof, Nucleic Acids Res. 2005, 33, 5677;
105. b) Q. Vicens, E. Westhof, Chem. Biol. 2002, 9, 747;
106. c) Q. Vicens, E. Westhof, J. Mol. Biol. 2003, 326, 1175;
107. d) Q. Vicens, E. Westhof, Structure 2001, 9, 647.
108. a) J. Tok, H. Bi, L. Bi, Top. Med. Chem. 2003, 3, 1001;
109. b) Y. Tor, ChemBioChem 2003, 4, 998;
110. c) X.-S. Ye, L. H. Zhang Curr. Med. Chem. 2002, 9, 929;
111. d) T. Hermann, Angew. Chem. 2000, 112, 1962;
112. Angew. Chem. Int. Ed. 2000, 39, 1890;
113. e) Y. Tor, Angew. Chem. 1999, 111, 1681;
114. Angew. Chem. Int. Ed. 1999, 38, 1579;
115. f) T. Hermann, E. Westhof, Curr. Opin. Biotechnol. 1998, 9, 66;
116. g) N. D. Pearson, C. D. Prescott, Chem. Biol. 1997, 4, 409.
117. a) R. E. Hornish, R. E. Gosline, J. M. Nappier, Drug Metab. Rev. 1987, 18, 177;
118. b) P. F. Hermans, Antimicrob. Agents Annu. 1986, 1, 103;
119. c) P. J. McDonald, Curr. Ther. Res. 1981, 22, 119.
120. a) B. J. Magerlein, F. Kagan, J. Med. Chem. 1969, 12, 780;
121. b) R. D. Birkenmeyer, F. Kagan, J. Med. Chem. 1970, 13, 616;
122. c) S. Douthwaite, Nucleic Acids Res. 1992, 20, 4717.
123. S. Hanessian, K. Sato, T. J. Liak, N. Danh, D. Dixit, J. Am. Chem. Soc. 1984, 106, 6114.
124. For example, see: a) A. L. Fitzhugh, Bioorg. Med. Chem. Lett. 1998, 8, 87;
125. b) L. Verdier, G. Berthe, J. Gharbi-Benarous, J.-P. Gireault, Bioorg. Med. Chem. 2000, 8, 1225.
126. a) S. Knapp, Chem. Rev. 1995, 95, 1859;
127. b) S. Hanessian, D. Dixit, T.-J. Liak, Pure Appl. Chem. 1981, 53, 129.
128. 2: K. Sakata, A. Sakurai, S. Tamura, Agric. Biol. Chem. 1973, 37, 697;
129. 1975, 39, 885, 3141;
130. 2: K. Sakata, A. Sakurai, S. Tamura, Tetrahedron Lett. 1975, 3191;
131. c) Octosyl acids: K. Isono, P. F. Crain, J. A. McCloskey, J. Am. Chem. Soc. 1975, 97, 943;
132. d) Malayamycin A: J. P. Benner, B. G. H. Boehlendorf, M. R. Kipps, N. E. P. Lambert, R. Luck, L.-P. Molleyres, S. Neff, T. C. Schuez, P. D. Stanley, WO 03/062242, 2003 [Chem. Abstr. 2003, 139, 132519].
133. For octosyl acid A, see: a) S. Danishefsky, R. Hungate, J. Am. Chem. Soc. 1986, 108, 2486;
134. b) S. Hanessian, J. Kloss, T. Sugawara, J. Am. Chem. Soc. 1986, 108, 2728;
135. c) S. Knapp, V. V. Thakur, M. R. Madduru, K. Malolanarasimhan, G. J. Morriello, G. A. Doss, Org. Lett. 2006, 8, 1335;
136. d) For an intermediate, see: J. D. More, N. S. Finnens, J. Org. Chem. 2006, 71, 2236;
137. For malayamycin A, see: e) S. Hanessian, S. Marcotte, R. Machaalani, G. Huang, Org. Lett. 2003, 5, 4277;
138. For the N analogues, see: f) S. Hanessian, G. Huang, C. Chenel, R. Machaalani, O. Loiseleur, J. Org. Chem. 2005, 70, 6721;
139. See also g) P. K. Sharma, M. Peterson, P. Nielsen, J. Org. Chem. 2005, 70, 4918;
140. h) E. Peris, A. Cavé, E. Estornell, M. C. Zaíra-Polo, B. Frigadère, D. Cortes, A. Bermejó, Tetrahedron 2002, 58, 1335;
141. i) J. Ravn, P. Nielsen, J. Chem. Soc. Perkin Trans. 1 2001, 985;
142. j) J. Oh, C. R. Lee, K. H. Chun, Tetrahedron Lett. 2001, 42, 4879;
143. k) M. A. Leeuwenburgh, C. Kulker, H. I. Dugnster, H. S. Overkleeft, G. A. van der Marel, J. Van Boom, Tetrahedron 1999, 55, 8253;
144. l) R. Meur, S. Grüschow, C. Leumann, Helv. Chim. Acta 1999, 82, 1813;
145. m) T. Oishi, Y. Nagumo, M. Hirama, Chem. Commun. 1998, 1041;
146. n) M. A. Leeuwenburgh, H. S. Overkleeft, G. A. van der Marel, J. van Boom, Synlett 1997, 1263;
147. o) J. S. Clark, J. G. Kettle, Tetrahedron Lett. 1997, 38, 127;
148. p) M. Delgado, J. D. Martin, Tetrahedron Lett. 1997, 38, 6299;
149. q) K. C. Nicolaou, H. D. Postema, C. I. Claiborne, J. Am. Chem. Soc. 1996, 118, 1565.
150. For reviews, see: a) L. Tietze, H. P. Bell, S. Chandrasekhar, Angew. Chem. 2003, 115, 4128;
151. Angew. Chem. Int. Ed. 2003, 42, 3996;
152. b) G. Mehta, V. Singh, Chem. Soc. Rev. 2002, 31, 324.
153. S. Hanessian, K. K. Kothakonda, Bioorg. Med. Chem. Lett. 2005, 15, 5283.
154. a) R. Leclercq, P. Courvallin, Antimicrob. Agents Chemother. 1991, 35, 1267;
155. b) B. Vester, S. Douthwaite, Antimicrob. Agents Chemother. 2001, 45, 1.
156. a) J. Zemlicka, M. C. Fernandez-Moyano, M. Ariatti, G. Zurenko, J. E. Grady, J. P. G. Ballesta, J. Med. Chem. 1993, 36, 1239;
157. b) P. Bhuta, H. L. Chung, J. S. Hwang, J. Zemlicka, J. Med. Chem. 1980, 23, 1299;
158. c) J. Zemlicka, A. Bhuta, J. Med. Chem. 1982, 25, 1123.
159. a) S. Magnet, Blanchard, Chem. Rev. 2005, 105, 477;
160. b) S. Varulenko, S. Mobashery, Clin. Microbiol. Rev. 2003, 3, 1001;
161. c) C. A. Smith, E. N. Baker, Curr. Drug Targets 2002, 2, 143;
162. d) D. H. Fong, A. M. Berghuis, EMBO J. 2002, 21, 2323;
163. e) J. Davies, Science 1994, 264, 375;
164. f) K. J. Shaw, P. N. Rather, R. S. Hare, G. H. Miller, Microbiol. Rev. 1993, 57, 138;
165. g) Aminoglycoside Antibiotics. Drug Action and Drug Resistance in Bacteria, Vol. 2 (Ed.: S. Mitsuhashi), University Park, Tokyo, 1975.
166. a) M. P. Mingeot-Leclercq, P. M. Tulkens, Antimicrob. Agents Chemother. 1999, 43, 1003;
167. b) M. P. Mingeot-Leclercq, Y. Glupczynski, P. M. Tulkens, Antimicrob. Agents Chemother. 1999, 43, 727.
168. a) J. Woodcock, D. Moazed, M. Cannon, J. Davies, H. F. Moller, EMBO J. 1991, 10, 3099;
169. b) J. Davies, B. D. Davis, J. Biol. Chem. 1968, 243, 3312;
170. for a recent review, see: B. Willis, D. P. Arya, Adv. Carbohydr. Chem. Biochem. 2006, 60, 251.
171. a) M. I. Fourmy, M. I. Recht, S. C. Blanchard, J. D. Puglisi, Science 1996, 274, 1367;
172. b) S. R. Lynch, R. L. Gonzalez, J. D. Puglisi, Structure 2003, 11, 43.
173. R. H. Griffey, S. A. Hofstadler, K. A. Sannes-Lowery, D. J. Ecker, S. T. Crooke, Proc. Natl. Acad. Sci. USA 1999, 96, 10 129.
174. a) S. Hanessian, A. Kornienko, E. E. Swayze, Tetrahedron 2003, 59, 995;
175. b) S. Hanessian, M. Tremblay, E. E. Swayze, Tetrahedron 2003, 59, 983;
176. c) S. Hanessian, M. Tremblay, A. Kornienko, N. Moitessier, Tetrahedron 2001, 57, 3255;
177. d) S. Hanessian, R. Massé, T. Nakagawa, Can. J. Chem. 1978, 56, 1509.
178. For selected examples, see: a) J. Li, H.-N. Chu, H. Chang, J. Wang, C.-W. T. Chang, Org. Lett. 2005, 7, 3061;
179. b) J. Haddad, L. P. Kotra, B. Llano-Sotelo, C. Kim, Jr., E. F. Azucena, M. Liu, S. B. Vakulenko, C. Chow, S. Mobashery, J. Am. Chem. Soc. 2002, 124, 3229;
180. c) K. Michael, H. Wang, Y. Tor, Bioorg. Med. Chem. Lett. 1999, 7, 1361;
181. d) B. P. Alper, M. Hendrix, P. Sears, C.-H. Wong, J. Am. Chem. Soc. 1998, 120, 1965;
182. K. Rosenbohm, D. Van den Berghe, A. Vlietinck, J. Wengel, Tetrahedron 2001, 57, 6277;
183. e) C. L. Nunns, L. A. Spence, M. J. Slater, D. J. Berrisford, Tetrahedron Lett. 1999, 40, 9341.
184. B. François, J. Szychowski, S. S. Adhikar, K. Pachamuthu, E. E. Swayze, P. H. Griffey, M. T. Migawa, E. Westhof, S. Hanessian, Angew. Chem. 2004, 116, 6903;
185. Angew. Chem. Int. Ed. 2004, 43, 6735.
186. a) S. Hanessian, J. Szychowski, K. Pachamuthu, E. E. Swayze, M. T. Migawa, unpublished observations;
187. b) S. Hanessian, J. Szychowski, S. S. Adhikari, K. Pachamuthu, M. Migawa, R. H. Griffey, WO 06/052930, 2006 [Chem. Abstr. 2006, 144, 468 397].
188. C.-H. Wong, M. Hendrix, E. S. Priestley, W. A. Greenberg, Chem. Biol. 1998, 5, 397.
189. For a review, see: A. M. Davis, S. J. Teague, Angew. Chem. 1999, 111, 778;
190. Angew. Chem. Int. Ed. 1999, 38, 736.
191. For reviews, see: a) E. L. Setti, R. G. Micetich, Curr. Med. Chem. 1998, 5, 101;
192. b) D. T. W. Chu, J. J. Plattner, L. Katz, J. Med. Chem. 1996, 39, 3853;
193. c) A. H. Berkó, Tetrahedron 1996, 52, 331;
194. d) O. A. Mascaretti, C. E. Boschetti, G. O. Damelon, E. G. Mata, O. Roveri, Curr. Med. Chem. 1995, 1, 441;
195. e) The Organic Chemistry of β-Lactams (Ed.: G. J. Georg), VCH, Weinheim, 1993.
196. For example, see: a) M. T. Black, G. Bruton, Ann. Pharm. Dev. 1998, 4, 123;
197. b) E. L. Setti, L. Quattrucchio, R. G. Micetich, Drug. Int. 1997, 22, 271;
198. K. Ehlert, Curr. Pharm. Dev. 1998, 15, 45.
199. a) F. C. Neuhaus, N. H. Georgeopapadakou in Emerging Targets in Antibacterial and Antifungal Chemotherapy (Eds.: J. Sutcliffe, N. H. Georgeopapadakou), Chapman and Hall, New York, 1992;
200. b) P. Actor, L. Daneo-Moore, M. L. Higgins, M. R. J. Salton, G. D. Shockman, Antibiotics Inhibition of Bacterial Cell Surface Assembly and Function; American Society for Microbiology, Washington, DC, 1988, p. 1-657.
201. J. L. Strominger, P. M. Blumberg, H. Suginaka, J. Umbreit, G. G. Wickus, Proc. R. Soc. London Ser. B 1971, 179, 369.
202. J. A. Kelly, J. R. Knox, H. Zhao, J.-M. Frère, J.-M. Ghuysen, J. Mol. Biol. 1989, 209, 281.
203. D. J. Tipper, J. L. Strominger, Proc. Natl. Acad. Sci. USA 1965, 54, 1133.
204. S. Hanessian, C. A. Couture, N. H. Georgeopapadakou, Bioorg. Med. Chem. Lett. 1993, 3, 2323.
205. P. H. Bentley, A.V. Stachulski, J. Chem. Soc. Perkin Trans. 1 1983, 1187.
206. a) W. J. Leanza, K. J. Wildonger, T. W. Miller, B. G. Christensen, J. Med. Chem. 1979, 22, 1435;
207. b) T. N. Saltzmann, R. W. Ratcliffe, B. G. Christensen, J. Am. Chem. Soc. 1980, 102, 6161;
208. c) D. H. Shih, F. Baker, L. Cama, B. G. Christensen, Heterocycles 1984, 21, 29.
209. A. Perboni, B. Tamburini, T. Rossi, D. Donati, G. Tarzia, G. Gaviraghi in Recent Advances in the Chemistry of Antiinfective Agents (Eds.: R. H. Bentley, R. Ponsford), The Royal Society of Chemistry, Cambridge, UK, 1992, p. 21.
210. For example, see: R. Camerini, M. Panunzio, G. Bonanomi, D. Donati, A. Perboni, Tetrahedron Lett. 1996, 37, 2467.
211. S. Hanessian, M. J. Rozema, J. Am. Chem. Soc. 1996, 118, 9884.
212. S. Hanessian, M. J. Rozema, G. B. Reddy, J. F. Braganza, Bioorg. Med. Chem. Lett. 1995, 5, 2535.
213. S. Hanessian, A. M. Griffin, M. J. Rozema, Bioorg. Med. Chem. Lett. 1997, 7, 1857.
214. J. R. Knox in Recent Advances in the Chemistry of Antiinfective Agents (Eds.: P. H. Bentley, P. Ponsford), Royal Society of Chemistry, Cambridge, UK, 1992, p. 36.
215. a) S. Hanessian, M. J. Rozema, Bioorg. Med. Chem. Lett. 1994, 4, 2279;
216. b) S. Hanessian, G. B. Reddy, Bioorg. Med. Chem. Lett. 1994, 4, 2285;
217. c) S. Hanessian, G. B. Reddy, Tetrahedron 1999, 55, 3427.
218. S. Hanessian, R. Buckle, M. Bayrakdarian, J. Org. Chem. 2002, 67, 3387.
219. For a review of nonclassical polycyclic β-lactams, see: M. Gomez-Gallego, M. J. Mancheno, M. A. Sierra, Tetrahedron 2000, 56, 5743.
220. a) T. D. Gootz, K. E. Brighty in The Quinolones (Ed.: V. T. Andiole), 2nd ed., Academic, New York, 1998, p. 29;
221. b) D. T. W. Chu, Ann. Rev. Med. Chem. 1998, 33, 141;
222. c) A. K. L. Fung, L. L. Shen, Curr. Pharm. Des. 1999, 5, 515;
223. d) M. Kidwai, P. Misra, R. Kumar, Curr. Pharm. Des. 1998, 4, 401.
224. For example, see: L. L. Shen, Adv. Pharmacol. 1994, 29 A, 285.
225. L. L. Shen, L. A. Mitscher, P. N. Sharma, T. J. O'Donnell, D. T. W. Chu, C. S. Cooper, T. Rosen, A. G. Pernet, Biochemistry 1989, 28, 3886.
226. For a different model, see: a) B. Llorente, F. Leclerc, R. Cedergren, Bioorg. Med. Chem. 1996, 4, 61;
227. b) J. Fam, D. Sun, S. M. Kerwiu, L. H. Hurley, J. Med. Chem. 1995, 38, 408;
228. c) M. Palumbo, B. Gatto, G. Zagotto, G. Palu, Trends Microbiol. 1993, 1, 232.
229. S. Hanessian, R. Saladino, J. C. Nunez, Bioorg. Med. Chem. Lett. 1996, 6, 2333.
230. a) A. S. Monto, I. A. Iacuzio, J. R. LaMontague, J. Infect. Dis. 1997, 176, 51;
231. b) R. F. Service, Science 1997, 275, 756;
232. c) H. Saul, New Sci. 1995, 26;
233. d) K.-J. Lui, A. P. Kendal, Am. J. Public Health 1987, 77, 712 ;
234. e) W. P. Glezen, Epidemiol. Rev. (Engl. Transl.) 1982, 4, 25.
235. F. G. Hayden, R. B. Belshe, R. D. Clover, A. J. Hay, M. G. Oakes, N. Soo, N. Engl. J. Med. 1989, 321, 1696.
236. a) F.G. Hayden, R. B. Couch, Rev. Med. Virol. 1992, 2, 89;
237. b) A. J. Hay, A.J. Wostenholme, J. J. Skenel, M. H. Smith, EMBO J. 1985, 4, 3021.
238. a) G. M. Air, W. G. Laver, Proteins Struct. Funct. Genet. 1989, 6, 348;
239. b) H.-D. Klenk, R. Rott, Adv. Virus Res. 1988, 34, 247;
240. c) N. A. Meanwell, M. Krystal, Drug Discovery Today 1996, 1, 316.
241. P. M. Colman in The Influenza Viruses: Influenza Virus Neuraminidase, Enzyme and Antigen (Ed.: R. M. King), Plenum, New York, 1989, p. 175.
242. a) J. H. Varghese, P. M. Colman, J. Mol. Biol. 1991, 221, 473;
243. b) J. N. Varghese, V. C. Epa, P. M. Colman, Protein Sci. 1995, 4, 108;
244. c) P. Bossart-Whitaker, M. Carson, Y. S. Babu, C. D. Smith, W. G. Laver, G. M. Air, J. Mol. Biol. 1993, 232, 1069;
245. d) J. N. Varghese, J. L. McKimm-Breschkin, J. B. Caldwell, A. A. Kortt, P. M. Colman, Proteins Struct. Funct. Genet. 1992, 14, 327;
246. e) W. P. Burmeister, R. W. H. Ruigroik, S. Cusack, EMBO J. 1992, 11, 49.
247. a) P. Meindl, G. Bodo, P. Palese, J. Schulman, H. Tuppy, Virology 1974, 58, 457;
248. b) C. T. Holzer, M. von Itzstein, B. Jin, M. S. Pegg, W. P. Stewart, W.-Y. Wu, Glycoconjugate J. 1993, 10, 40.
249. M. von Itzstein, Y. Wu, G. B. Kok, M.S. Pegg, J. C. Dyason, B. Jiu, T. Van Phan, M. L. Synthe, H. F. White, S. W. Oliver, P. G. Colman, V. J. Varghese, J. M. Cameron, C. R. Penn, Nature 1993, 363, 418.
250. a) C. U. Kim, W. Lew, M. A. Williams, H. T. Liu, L. J. Zhang, S. Swaminathan, N. Bischofberger, M. S. Chen, D. B. Mendel, C. Y. Tai, W. G. Laver, R. C. Stevens, J. Am. Chem. Soc. 1997, 119, 681;
251. b) W. Lew, X. Chen, C. U. Kim, Curr. Med. Chem. 2000, 7, 663;
252. S. Albrecht, P. Harrington, H. Iding, M. Karpf, R. Trussardi, B. Wirz, U. Zatter, Chimia 2004, 58, 621.
253. For efficient syntheses of Oseltamivir, see: a) Y.-Y. Yeung, S. Hong, E. J. Corey, J. Am. Chem. Soc. 2006, 128, 6310;
254. b) Y. Fukuta, T. Mita, N. Fukuda, M. Kanai, M. Shibasaki, J. Am. Chem. Soc. 2006, 128, 6312.
255. C. Zhao, C. Maring, M. Sun, K. Stewart, V. Stoll, Y. Xu, Y. Gu, A. Krueger, T. Herrin, H. Sham, W. G. Laver, D. Madigan, A. Kennedy, W. Kati, D. Montgomery, A. Saldivar, D. Kempf, W. Kohlbrenner, Thirteenth International Conference on Antiviral Research, Baltimore, MD (USA), April; Antiviral Research 2000, Vol. 46, p. A53, Abstract 58.
256. Y. S. Babu, P. Chand, S. Bantia, P. Kotian, A. Dehghani, Y. El-Kattan, T.-H. Liu, T. L. Hutchinson, A. J. Elliott, C. D. Parker, S. L. Ananth, L. L. Horn, G. W. Laver, J. A. Montgomery, J. Med. Chem. 2000, 43, 3482.
257. S. Hanessian, J. Wang, D. Montgomery, V. Stoll, K. D. Stewart, W. Kati, C. Maring, D. Kempf, C. Hutchins, W. G. Laver, Bioorg. Med. Chem. Lett. 2002, 12, 3425.
258. S. Hanessian, M. Bayrakdarian, X. Luo, J. Am. Chem. Soc. 2002, 124, 4716.
259. a) D. A. Degoey, H.-J. Chen, W. J. Flosi, D. J. Grampovnik, C. M. Yeung, L. L. Klein; D. J. Kempf, J. Org. Chem. 2002, 67, 5445;
260. b) D. M. Barnes, M. A. McLaughlin, T. Oie, M. W. Rasmussen, K. D. Steward, S. J. Wittenberger, Org. Lett. 2002, 4, 1427.
261. For recent reviews, see: a) B. G. Rao, Curr. Pharm. Des. 2005, 11, 295;
262. b) K. Maskos, Biochimie 2005, 87, 249;
263. c) P. Vihinem, R. Ala-aho, V. Kahari, Curr. Cancer Drug Targets 2005, 5, 203;
264. d) F. Manuello, G. Torti, S. Papa, Curr. Cancer Drug Targets 2005, 5, 285;
265. e) J. W. Skiles, N. C. Gonnella, A. Y. Jeng, Curr. Med. Chem. 2001, 8, 425;
266. f) M. Whittaker, C. D. Floyd, P. Brown, A. J. H. Gearing, Chem. Rev. 1999, 99, 2735;
267. g) M. R. Michaelidis, M. L. Curtin, Chem. Pharm. Des. 1999, 5, 787;
268. h) H. S. Rasmussen, P. P. McCann, Pharmacol. Ther. 1997, 75, 69.
269. F. Grams, M. Crimmin, L. Hinnes, P. Huxley, M. Pieper, H. Tschesche, W. Bode, Biochemistry 1995, 34, 14 012.
270. a) Y.-C. Li, X. Zhang, R. Melton, V. Ganu, N. C. Gonnella, Biochemistry 1998, 37, 14 048;
271. b) L. J. MacPherson, E. K. Bayburi, M. P. Capparelli, B. J. Carroll, R. Goldstein, M. R. Justice, L. Zhu, S.-I. Hu, R. A. Melton, L. Fryer, R. L. Goldberg, J. R. Doughty, S. Spirits, V. Blancuzzi, D. Wilson, E. M. O'Byrne, V. Ganu, D. T. Parker, J. Med. Chem. 1997, 40, 2525;
272. c) N. C. Gonnella, Y.-C. Li, X. Zhang, C. G. Paris, Bioorg. Med. Chem. 1997, 5, 2193.
273. a) S. Hanessian, N. Moitessier, C. Gauchet, M. Viau, J. Med. Chem. 2001, 44, 3066;
274. b) S. Hanessian, S. Bouzbouz, A. Boudon, G. C. Tucker, D. Peyroulan, Bioorg. Med. Chem. Lett. 1997, 7, 3119.
275. a) S. Hanessian, D. B. Mackay, N. Moitessier, J. Med. Chem. 2001, 44, 3074
276. b) S. Hanessian, A. Griffin, P. V. Devasthale, Bioorg. Med. Chem. Lett. 1997, 7, 3119;
277. c) S. Hanessian, L.-D. Cantin, Tetrahedron Lett. 2000, 41, 787;
278. d) S. Hanessian, N. Moitessier, S. Wilmouth, Tetrahedron 2000, 56, 7643;
279. e) S. Hanessian, N. Moitessier, L.-D. Cantin, Tetrahedron 2001, 57, 6885.
280. a) S. Hanessian, N. Moitessier, E. Therrien, J. Comput.-Aided Mol. Des. 2001, 15, 873;
281. b) S. Hanessian, N. Moitessier, Curr. Top. Med. Chem. 2004, 4, 1269.
282. a) E. M. F. Muri, M. J. Nieto, R. D. Sindelar, J. D. Williamson, Curr. Med. Chem. 2002, 9, 1631;
283. b) K. Yang, B. Lou, Mini-Rev. Med. Chem. 2003, 3, 349.
284. J. Wu, M. Grunstein, Trends Biochem. Sci. 2005, 25, 619.
285. S. Minucci, P. G. Pelicci, Nat. Rev. Cancer 2006, 6, 38.
286. O. Moradei, C. R. Maroun, I. Paquin, A. Vaisburg, Curr. Med. Chem. 2005, 5, 529.
287. a) M. Yoshida, M. Kijimo, M. Akita, T. Beppu, J. Biol. Chem. 1990, 265, 17 174;
288. b) K. Mori, K. Koseki, Tetrahedron 1998, 54, 6013.
289. a) L. K. Gediya, C. P. Pankaj, P. Purashottamachar, N. Maheshwari, V. C. O. Njar, J. Med. Chem. 2005, 48, 5047;
290. b) L. Butler, D. B. Agers, H. I. Scher, B. Higgens, A. Rose, C. Cordon-Cardo, H. T. Thaler, R. A. Rifkind, P. Marks, V. M. Richon, Cancer Res. 2000, 60, 5165;
291. c) V. M. Richon, S. Emiliani, E. Verdiu, Y. Webb, R. Breslow, R. A. Rifkind, P. A. Marks, Proc. Natl. Acad. Sci. USA 1998, 95, 3003.
292. a) M. S. Finnin, J. R. Donigian, A. Cohen, V. M. Richou, R. A. Rifkind, P. A. Marks, R. Breslow, N. P. Pavletich, Nature 1999, 401, 188;
293. b) J. R. Somoza, R. J. Skene, B. A. Katz, C. Mol, J. D. Ho, A. J. Jennings, C. Luong, A. Arvai, J. J. Buggy, E. Chi, J. Tang, B.-C. Sang, E. Verner, R. Wynands, E. M. Leahy, D. R. Dougan, G. Snell, M. Navre, M. W. Knuth, R. V. Swanson, D. E. McRee, L. W. Tari, Structure 2004, 12, 1325;
294. c) A. Vannini, C. Volpari, G. Filocarno, E. C. Casavola, M. Brunetti, D. Renzoni, P. Chakravarty, C. Paolini, R. D. Francesco, P. Galinnari, C. Streinkühler, S. D. Marco, Proc. Natl. Acad. Sci. USA 2004, 101, 15 064.
295. S. Hanessian, V. Vinci, L. Auzzas, M. Marzi, G. Giannini, Bioorg. Med. Chem. Lett. 2006, 16, 4784.
296. M. Bredel, Brain Res. Rev. 2001, 35, 161.
297. a) A. A. Brandes, U. Basso, L. M. Pasetto, M. Ermani, Curr. Pharm. Des. 2001, 7, 1553;
298. b) H. B. Newton, Expert Opin. Invest. Drugs 2000, 9, 2915.
299. a) J. Rahuel, B. Gay, D. Erdmann, A. Strauss, G. Garcia-Echeveria, P. Furet, G. Caravatti, H. Fretz, J. Shoepfer, M. G. Grutter, Nat. Struct. Biol. 1996, 3, 586;
300. b) G. Waksman, S. E. Shoelson, N. Pant, D. Cowburn, J. Kuiryan, Cell 1993, 72, 779.
301. S. Hanessian, O. M. Saavedra, F. Xie, N. Amboldi, C. Battistini, Bioorg. Med. Chem. Lett. 2000, 10, 439.
302. S. Hanessian, L. Zhan, R. Bovey, O. M. Saavedra, L. Juillerat-Jeanneret, J. Med. Chem. 2003, 46, 3600.
303. G. M. Ramos, D. Tombo, D. Bellus, Angew. Chem. 1991, 103, 1219;
304. Angew. Chem. Int. Ed. Engl. 1991, 30, 1193.
305. a) H. Haruyama, T. Takayama, T. Kinoshita, M. Kondo, M. Nakajima, T. Haneishi, J. Chem. Soc. Perkin Trans. 1 1991, 1637;
306. b) J. P. Pachlatko, H. Zähner, DE-B 4129-616A1, 1992.
307. C. Kang, H. J. Fromm, J. Biol. Chem. 1995, 270, 15 539.
308. a) R. Fonne-Pfister, P. Chemla, E. Ward, K. E. Girardet, R. B. Kreuz, R. B. Honzatko, H. J. Fromm, M. G. Schär, M. G. Grütter, S. W. Cowan-Jacob, Proc. Natl. Acad. Sci. USA 1996, 93, 943;
309. b) E. W. Walters, S. Lee, T. Niderman, P. Bernasconi, M. V. Subramanian, D. Sichl, Plant Physiol. 1997, 114, 549;
310. c) C. Cseke, B. C. Gerwick, G. D. Crouse, M. G. Murdoch, S. B. Green, D. R. Heim, Pestic. Biochem. Physiol. 1996, 55, 250.
311. M. D. Hatch, Phytochemistry 1967, 6, 115.
312. B. W. Poland, S. Lee, M. V. Subramanian, D. Sichl, R. J. Anderson, H. J. Frown, R. B. Honzatko, Biochemistry 1996, 35, 15 753.
313. Sistine Chapel, the Vatican Museum, Vatican City, Italy.
314. S. Hanessian, P. P. Lu, J.-Y. Sancéau, P. Chemla, K. Gohda, R. Fonné-Pfister, L. Prade, S. W. Cowan-Jacob, Angew. Chem. 1999, 111, 3354;
315. Angew. Chem. Int. Ed. 1999, 38, 3159.
316. a) E. Skordalakes, S. Elgendy, C. A. Goodwin, D. Gree, M. F. Scully, V. Kakkar, J. M. Freyssinet, G. Dodson, J. J. Deadman, Biochemistry 1998, 37, 14 420;
317. b) J. P. Priestle, J. Rahuel, H. Rink, M. Tones, M. G. Gruetter, Protein Sci. 1993, 2, 1630;
318. c) A. Ricouart, J. C. Gesquiere, A. Tartar, C. J. Sergheraert, J. Med. Chem. 1991, 34, 73.
319. S. Hanessian, S. Marcotte, R. Machaalani, G. Huang, J. Pierron, O. Loiseleur, Tetrahedron 2006, 62, 5201.
320. S. Hanessian, R. Machaalani, Tetrahedron Lett. 2003, 44, 8321.
321. a) W. R. Gould, R. Leadley, Curr. Pharm. Des. 2003, 9, 2337;
322. b) K. A. Jacobson, S. Constanzi, M. Ohno, B. V. Joshi, P. Besada, B. Xu, S. Tchilibon, Curr. Top. Med. Chem. 2004, 4, 805.
323. a) D. Gustafsson, R. Byland, T. Antonsson, I. Nilsson, J.-E. Nystrom, U. Eriksson, U. Bredberg, A.-C. Teger-Nilsson, Nat. Rev. Drug Discovery 2004, 3, 649;
324. b) P. Petersen, Curr. Pharm. Des. 2005, 11, 527.
325. a) M. J. Ryan, C. D. Sigmund, Circ. Res. 2004, 94, 1;
326. b) M. C. White, Pharmacotherapy 1998, 18, 588.
327. K. R. Acharya, E. D. Sturrock, J. F. Riordan, M. R. Ehlers, Nat. Rev. Drug Discovery 2003, 2, 891.
328. S. Hanessian, U. Reinhold, G. Gentile, Angew. Chem. 1997, 109, 1953;
329. Angew. Chem. Int. Ed. Engl. 1997, 36, 1881.
330. S. Hanessian, U. Reinhold, M. Saulnier, S. Claridge, Bioorg. Med. Chem. Lett. 1998, 8, 213.
331. D. R. Magnin, J. A. Robl, R. B. Sulsky, D. Augeri, Y. Huang, L. Simpkins, P. C. Taunk, D. A. Betebener, J. G. Robertson, B. E. Abbao-Offei, A. Wang, M. Cap, L. Xiu, L. Tao, D. F. Sitkoff, M. F. Malley, J. Z. Gougoutas, A. Khanna, Q. Huang, S.-P. Hau, R. A. Parker, L. G. Haman, J. Med. Chem. 2004, 47, 2583.
332. A. Reichelt, S. F. Martin, Acc. Chem. Res. 2006, 39, 433.
333. a) M. B. Valloton, Trends Pharmacol. Sci. 1987, 8, 69;
334. J. Boger, Trends Pharmacol. Sci. 1987, 8, 370;
335. b) A. A. Patchett, E. H. Cordes, Adv. Enzymol. 1985, 57, 1;
336. for selected reviews, see: c) W. J. Greenlee, Med. Res. Rev. 1990, 10, 173;
337. d) H. D. Kleinert, Expert Opin. Invest. Drugs 1994, 3, 1087;
338. e) T. D. O'Cain, M. Abou-Gharbia, Drugs Future 1991, 6, 37;
339. f) C. Hutchins, J. Greer, Crit. Rev. Biochem. Mol. Biol. 1991, 26, 77.
340. a) A. Stanton, Am. J. Cardiovasc. Drugs 2003, 3, 389;
341. b) J. M. Wood, J. Maibaum, J. Rahuel, M. G. Grutter, N. C. Cohen, V. Rasetti, H. Roger, R. Goschke, S. Stutz, W. Fuhrer, W. Schilling, P. Rigollier, Y. Yamaguchi, F. Cumin, H. P. Baum, G. R. Schnell, P. Herold, R. Mah, C. Jensen, E. O'Brien, A. Stanton, M. P. Bedigian, Biochem. Biophys. Res. Commun. 2003, 308, 698;
342. c) J. Rahuel, V. Rasetti, J. Maibaum, H. Rüegger, R. Göschke, N. C. Cohen, S. Stutz, F. Cumin, W. Fuhrer, J. M. Wood, M. G. Grütter, Chem. Biol. 2001, 8, 493;.
343. a) S. Hanessian, S. Claridge, S. Johnstone, J. Org. Chem. 2002, 67, 4261;
344. b) S. Hanessian, S. Raghavan, Bioorg. Med. Chem. Lett. 1994, 4, 1696.
345. a) K. B. Lindsay, T. Skrydrup, J. Org. Chem. 2006, 71, 4766;
346. b) H. Dong, Z.-L. Zhang, J.-H. Huang, R. Ma, S.-H. Chen, G. Li, Tetrahedron Lett. 2005, 46, 6337;
347. c) A. Dondoni, G. Delathauwer, D. Perrone, Tetrahedron Lett. 2001, 42, 4819;
348. d) P. Herold, S. Stutz, A. Indolese, WO 109083, 2001 [Chem. Abstr. 2001, 134, 162 829];
349. e) H. Rüegger, S. Stutz, R. Göschke, F. Spindler, J. Maibaum, Tetrahedron Lett. 2000, 41, 10 085;
350. f) D. A. Sandham, R. Taylor, J. S. Carey, A. Fässler, Tetrahedron Lett. 2000, 41, 10 091;
351. g) For a QSAR study, see: S. P. Gupta, Mini-Rev. Med. Chem. 2003, 3, 315.
352. a) A. J. Turner, L. Murphy, Biochem. Pharmacol. 1996, 51, 91;
353. b) J. Vane, T. Masaki, P. M. Vanhoutte, R. J. Botting, J. Cardiovasc. Pharmacol. 1995, 26, 5;
354. c) M. A. Polokoff, Pharmacol. Rev. 1994, 46, 325.
355. a) A. Inoue, M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, T. Masaki, Proc. Natl. Acad. Sci. USA 1989, 86, 2863;
356. b) M. Yanagisawa, H. Kurishara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, T. Masaki, Nature 1988, 332, 411.
357. a) A. Y. Jeng, Curr. Opin. Invest. Drugs 2003, 4, 1076;
358. b) W. G. Haynes, D. J. Webb, J. Hypertens. 1988, 6, 1081;
359. c) S. Vemulappali, N. Chirallo, A. Stanford, R. Watkins, P. Chiu, E. Sybertz, A. B. Fawzi, Cardiovasc. Drug Rev. 1997, 15, 260.
360. a) A. Y. Jeng, P. Mulder, A.-L. Kwao, B. Battistini, Can. J. Physiol. Pharmacol. 2002, 80, 440;
361. b) W. Otter, M. Keotsch, Curr. Opin. Cardiovasc. Pulm. Renal Invest. Drugs 2000, 2, 316.
362. S. Hanessian, C. Gauchet, G. Charron, J. Marin, P. Nakache, J. Org. Chem. 2006, 71, 2760.
363. a) W. Bode, H. Brandstetter, T. Mather, M. T. Stubbs, Thromb. Haemostasis 1997, 78, 501;
364. b) R. W. Colman, A. W. Clowes, J. N. George, J. L. Hirsch, J. V. Marder in Hemostasis and Thrombosis. Basic Principles and Clinical Practice (Eds.: R. W. Colman, J. L. Hirsh, J. V. Marder, A. W. Clowes, J. N. George), Lippincott Williams & Wilkins, Philadelphia, 2001, p. 3;
365. c) B. Dahlbäck, Lancet 2000, 355, 1627;
366. d) T. Steinmetz, J. Hauptman, J. Stürzbecher, Expert Opin. Invest. Drugs 2000, 10, 845;
367. e) S. D. Kimball, Blood Coagulation Fibrinolysis 1995, 6, 511.
368. a) P. Tadeusz, W. Cezary, Biotechnologia 1996, 3, 34;
369. c) P. H. Johnson, Annu. Rev. Med. 1994, 45, 165;
370. b) J. Lefkovitz, E. J. Topol, Circulation 1994, 90, 1522.
371. a) X. Qui, K. P. Padmanabhan, V. E. Carperos, A. Tulinsky, T. Kline, J. M. Marayanone, J. W. Fenton, Biochemistry 1992, 31, 11 689;
372. b) W. Bode, I. Mayr, U. Baumann, R. Uber, S. R. Stone, J. Hofskeenge, EMBO J. 1989, 8, 3467.
373. a) R. St-Charles, J. H. Matthews, E. Zhang, A. Tulinsky, J. Med. Chem. 1999, 42, 1376;
374. b) J. Wagner, J. Kallen, C. Ehrhardt, J.-P. Evenou, D. Wagner, J. Med. Chem. 1998, 41, 3664;
375. c) J. S. Plummer, K. A. Berryman, C. Cai, W. L. Cody, J. DiMaio, A. M. Doherty, J. J. Edmunds, J. X. He, D. R. Holland, S. Levesque, D. R. Kent, L. S. Narasimhau, J. R. Rubin, S. T. Rapundalo, M. A. Siddiqui, A. Susser, Y. St-Denis, P. D. Winecour, Bioorg. Med. Chem. Lett. 1998, 8, 3409;
376. d) K. Lee, W.-H. Jung, C. W. Park, C. Hong, I. C. Kim, S. Kim Y. S. Oh, O. H. Kwon, S.-H. Lee, H. D. Park, S. W. Kim, Y. H. Lee, Y. J. Yoo, Bioorg. Med. Chem. Lett. 1998, 8, 2563.
377. For reviews, see: a) R. M. Scarborough, A. Pandey, X. Zhang, Annu. Rep. Med. Chem. 2005, 40, 85;
378. b) R. Pfau, Curr. Opin. Drug Discovery Dev. 2003, 6, 437;
379. c) P. E. J. Sanderson, A. M. Naylor-Olsen, Curr. Med. Chem. 1998, 5, 289;
380. d) W. C. Ripka, Curr. Opin. Chem. Biol. 1997, 1, 242.
381. See AstraZeneca press release: http://www.exanta.com/content3682.htm
382. S. Hanessian, E. Balaux, D. Musil, L.-L. Olsson, I. Nilsson, Bioorg. Med. Chem. Lett. 2000, 10, 243.
383. S. Hanessian, E. Therrien, K. Granberg, I. Nilsson, Bioorg. Med. Chem. Lett. 2002, 12, 2907.
384. S. Hanessian, H. Sailes, A. Munro, E. Therrien, J. Org. Chem. 2003, 68, 7219.
385. S. Hanessian, H. Sailes, E. Therrien, Tetrahedron 2003, 59, 7047.
386. a) L. Manzoni, L. Belvisi, E. DiCarlo, A. Forni, D. Invernizzi, C. Scolastico, Synthesis 2006, 113;
387. b) R. Kaul, S. Surprenant, W. D. Lubell, J. Org. Chem. 2005, 70, 3839;
388. c) W. Wang, C. Xiong, V. Hurby, Tetrahedron Lett. 2001, 42, 3159;
389. d) J. Mulzer, F. Schülzchen, J.-W. Bats, Tetrahedron 2000, 56, 4289;
390. e) W. Chu, K. K. Moeller, Tetrahedron Lett. 1999, 40, 7939;
391. f) P. Wessig, Tetrahedron Lett. 1999, 40, 5987;
392. g) F. Polyak, W. J. Lubell, J. Org. Chem. 1998, 63, 5937;
393. h) H.-O. Kim, M. Kahn, Tetrahedron Lett. 1997, 38, 6483;
394. i) R. Mueller, L. Revesz, Tetrahedron Lett. 1997, 38, 6483;
395. j) L. Colombo, M. DiGiacomo; G. Papeo, O. Carugo, C. Scolastico, L. Manzoni, Tetrahedron Lett. 1994, 35, 4031;
396. k) J. A. Robl, Tetrahedron Lett. 1994, 35, 393;
397. for reviews see l) W. Maison, A. Prenzel, Synthesis 2005, 1031;
398. m) J. Cluzeau, W. D. Lubell, Biopolymers 2005, 80, 98;
399. n) S. Hanessian, G. McNaughton-Smith, H.-G. Lombart, W. D. Lubell, Tetrahedron 1997, 53, 12 789;
400. o) P. Gillespie, J. Cicariello, G. L. Olson, Biopolymers Peptide Sci. 1997, 43, 191.
401. S. Hanessian, E. Therrien, W. A. L. van Otterlo, M. Bayrakdarian, I. Nilsson, O. Fjellstrom, Bioorg. Med. Chem. Lett. 2006, 16, 1032.
402. W. Pan, T. Lu, T. P. Markotan, B. E. Tomczuk, WO 02/028825, 2002 [Chem. Abstr. 2002, 136, 294 655].
403. a) H. Matsuda, T. Okino, M. Murakami, K. Yamaguchi, Tetrahedron 1996, 52, 14 501;
404. b) M. Murakami, K. Ishida, T. Okino, Y. Okita, H. Matsuda, K. Yamaguchi, Tetrahedron Lett. 1995, 36, 2785;
405. c) M. Murakami, Y. Okita, H. Matsuda, H. Okino, K. Yamaguchi, Tetrahedron Lett. 1994, 35, 3129.
406. For recent reviews, see: a) H. Leusch, G. G. Harrigan, G. Goetz, F. D. Horgen, Curr. Med. Chem. 2002, 9, 179;
407. b) A. M. Burja, B. Banaigs, E. Abou-Mansour, J.-G. Burgess, P. C. Wright, Tetrahedron 2001, 57, 9347;
408. c) T. Shiori, Y. Hamada, Synlett 2001, 184;
409. d) J. R. Lewis, Nat. Prod. Rep. 1998, 15, 417;
410. e) M. Namikoshi, K. L. Rinehart, J. Ind. Microbiol. 1996, 17, 373;
411. f) K. L. Rinehart, M. Namikoshi, B. W. Choi, J. Appl. Phycol. 1994, 6, 159.
412. For a review, see: J. Del Valle, K. Ersmark, S. Hanessian, manuscript in preparation.
413. Total syntheses of aeruginosin 298A and 298B: a) T. Ohshima, V. Gnanadesikan, T. Shibuguchi, Y. Fukuta, T. Nemoto, M. Shibasaki, J. Am. Chem. Soc. 2003, 125, 11 206;
414. b) N. Valls, M. López-Canet, M. Vallribera, J. Bonjoch, Chem. Eur. J. 2001, 7, 3446;
415. c) J.-L. Methot, P. Wipf, Org. Lett. 2000, 2, 4213;
416. d) N. Valls, M. López-Canet, M. Vallribera, J. Bonjoch, J. Am. Chem. Soc. 2000, 122, 11 248;
417. e) Aeruginosin EI461: N. Valls, M. Vallribera, S. Carmeli, J. Bonjoch, Org. Lett. 2003, 5, 447;
418. f) Microcin SF608: N. Valls, M. Vallribera, M. López-Canet, J. Bonjoch, J. Org. Chem. 2002, 67, 4945;
419. for a "library" approach, see: T. Doi, Y. Hoshina, H. Mogi, Y. Yamada, T. Takahashi, J. Comb. Chem. 2006, 8, 571.
420. J. L. Rios Teiner, M. Murakami, A. Tulinsky, J. Am. Chem. Soc. 1998, 120, 597.
421. A. R. Caroll, G. Pierens, G. Fechner, G. P. de Almeida Leone, M. Simpson, J. N. Hooper, S.-L. Boström, D. Musil, R. J. Quinn, J. Am. Chem. Soc. 2002, 124, 13 340.
422. S. Hanessian, R. Margarita, A. Hall, S. Johnstone, M. Tremblay, L. Parlanti, J. Am. Chem. Soc. 2002, 124, 13 342.
423. a) R. Engh, S. Konetschny-Rapp, H.-W. Krell, U. Martin, WO 96/11941 [Chem. Abstr. 124, 315 175];
424. b) R. Engh, S. Konetschny-Rapp, H.-W. Krell, U. Martin, C. Tsaklakidis, WO 97/21725 [Chem. Abstr. 127, 122 002].
425. S. Hanessian, M. Tremblay, J. F. W. Petersen, J. Am. Chem. Soc. 2004, 126, 6064.
426. G. H. Goetz, G. G. Harrigan, J. J. Likos, T. P. Kasten, WO 03/051831.
427. S. Hanessian, J. Del Valle, Y. Xue M. Blomberg, J. Am. Chem. Soc. 2006, 128, 10 491 and 11 727.
428. For recent examples of aeuruginosin core analogues, see: a) Z. Liu, J. D. Ranier, Org. Lett. 2006, 8, 459;
429. b) X. Nie, G. Wang, J. Org. Chem. 2005, 70, 8687;
430. c) Y. Fukuta, T. Ohshima, V. Gnanadesikan, T. Shibuguchi, T. Nemoto, T. Kisugi, T. Okino, M. Shibasaki, Proc. Natl. Acad. Sci. USA 2004, 101, 5433;
431. d) N. Toyooka, A. Nakazawa, T. Himiyama, H. Nemoto, Heterocycles 2003, 59, 75;
432. e) N. Toyooka, M. Okumura, T. Himiyama, A. Nakazawa, H. Nemoto, Synlett 2003, 55;
433. f) N. Valls, M. Vallribera, M. Font-Bardia, X. Solans, J. Bonjoch, Tetrahedron: Asymmetry 2003, 14, 1241;
434. g) G. Radau, J. Stürzebecher, Pharmazie 2002, 57, 11;
435. h) G. Radau, D. Rauh, Bioorg. Med. Chem. Lett. 2000, 10, 779;
436. i) J. Bonjoch, J. Catena, E. Isábal, M. López-Canet, N. Valls, Tetrahedron: Asymmetry 1996, 7, 1999;
437. j) P. Wipf, Y. Kim, Tetrahedron Lett. 1992, 33, 5477;
438. k) R. Henning, H. Urbach, Tetrahedron Lett. 1983, 24, 5339.
439. For methodology resulting from aeruginosin chemistry, see: a) S. Hanessian, M. Tremblay, M. Marzi, J. Del Valle, J. Org. Chem. 2005, 70, 5070;
440. b) S. Hanessian, M. Tremblay, Org. Lett. 2004, 6, 4683.
441. B. R. Belleau, Chem. Can. 1980, 24.
442. For authoritative treatises and monographs, see: a) J. V. Aldrich in Burger's Medicinal Chemistry and Drug Discovery, Vol. 3 (Ed.: M. E. Wolff), Wiley, New Yrok, 1996, p. 321;
443. b) Comprehensive Medicinal Chemistry II (Eds: J. B. Taylor, D. J. Triggle), Elsevier, Amsterdam, 2006;
444. c) The Practice of Medicinal Chemistry (Ed.: C. Wermuth), Academic, New York, 2003.
445. J. Hardy, D. J. Selkoe, Science 2002, 297, 353.
446. a) C. Szàntay, G. Dörnyei, G. Baskó in The Alkaloids, Vol. 45 (Eds.: G. A. Cordell, A. Brossi), Academic, New Yrok, 1994, p. 127;
447. b) A. F. Casy, R. T. Parfitt, Opioid Analgesics: Chemistry and Receptors, Plenum, New York, 1986;
448. c) D. Lednicer, Central Analgesics, Wiley, New York, 1982, p. 137.
449. a) T. S. Stevens, E. M. Creighton, A. B. Gordon, M. MacNicol, J. Am. Chem. Soc. 1928, 50, 3193;
450. b) S. H. Pine, Org. React. 1970, 18, 403;
451. c) H. Takayama, T. Nemoto, T. Suzuki, M. Takamoto, T. Okamoto, Heterocycles 1978, 9, 1545;
452. d) I. E. Markó in Comprehensive Organic Synthesis, Vol. 3, (Eds.: B. M. Trost, I. Fleming, G. Pattenden), Pergamon, Oxford, 1991, p. 913.
453. a) S. Hanessian, M. Mauduit, E. Demont, C. Talbot, Tetrahedron 2002, 58, 485;
454. b) S. Hanessian, C. Talbot, S. Parthasarathy, Synthesis 2006, 4, 723;
455. c) S. Hanessian, M. Mauduit, Angew. Chem. 2001, 113, 3926;
456. Angew. Chem. Int. Ed. 2001, 40, 3810.
457. S. Hanessian, S. Parthasarathy, M. Mauduit, K. Payza, J. Med. Chem. 2003, 46, 34.
458. D. Selkoe, Annu. Rev. Pharmacol. Toxicol. 2003, 43, 545.
459. a) R. Vassar, J. Mol. Neurosci. 2004, 23, 105;
460. b) X. Lin, G. Koelsch, S. Wu, D. Downs, A. Dashti, J. Tang, Proc. Natl. Acad. Sci. USA 2000, 97, 1456.
461. a) L. A. Thomson, J. J. Brown, F. C. Zusi, Curr. Chem. Des. 2005, 11, 3383;
462. b) M. Citron, Trends Pharmacol. Sci. 2004, 14, 1;
463. c) I. Hussain, Invest. Drugs 2004, 7, 653;
464. d) T. E. Golde, J. Clin. Invest. 2003, 111, 11;
465. e) K. A. Conway, E. W. Baxter, K. M. Felsenstein, A. B. Reitz, Curr. Pharm. Des. Nat. Rev. 2003, 9, 427;
466. f) S. M. Wolfe, Drug Discovery 2002, 1, 859.
467. a) L. Hong, G. Koelsch, X. Lin, W. S. Wu, S. Terzyan, A. K. Ghosh, X. C. Zhang, J. Tang, Science 2000, 290, 150;
468. b) L. Hong, R. T. Turner, G. Koelsch, D. Shin, A. K. Ghosh, J. Tang, Biochemistry 2002, 41, 10 963.
469. S. Hanessian, H. Yun, Y. Hou, G. Yang, M. Bayrakdarian, E. Therrien, N. Moitessier, S. Roggo, S. Veenstra, M. Tintlenot-Blomley, J.-M. Rondeau, C. Ostermeier, A. Strauss, P. Ramage, P. Paganetti, U. Neumann, C. Betschart, J. Med. Chem. 2005, 48, 5175.
470. S. Hanessian, Y. Hou, M. Bayrakdarian, M. Tintlenot-Blomley, J. Org. Chem. 2005, 70, 6735.
471. S. Hanessian, H. Yun, Y. Hou, M. Tintlenot-Blomley, J. Org. Chem. 2005, 70, 6746.
472. a) J. D. A. Tyndall, D. P. Fairlie, Curr. Med. Chem. 2001, 8, 893;
473. b) J. D. A. Tyndall, T. Nall, D. P. Fairlie, Chem. Rev. 2005, 105, 973.
474. S. Hanessian, G. Yang, J.-M. Rondeau, U. Neumann, C. Betschart, M. Tintlenot-Blomley, J. Med. Chem. 2006, 49, 4544.
475. a) S. J. Miller, H. E. Blackwell, R. H. Grubbs, J. Am. Chem. Soc. 1996, 118, 9606;
476. b) M. Scholl, S. Ding, C. W. Lee, R. H. Grubbs, Org. Lett. 1999, 1, 953.
477. For example, see: a) Ivermectin and Abamectin (Ed.: W. C. Campbell), Springer, New York, 1989;
478. b) T. Blizzard, M. H. Fisher, H. Mrozik, T. L. Shih in Recent Progress in the Chemical Synthesis of Antibiotics (Eds.: G. Lukacs, M. Ohno), Springer, Heidelberg, 1990, chap. 3, p. 65.
479. a) S. Hanessian, A. Ugolini, D. Dubé, P. J. Hodges, C. André, J. Am. Chem. Soc. 1986, 108, 2776;
480. b) S. Hanessian, D. Dubé, P. I. Hodges, J. Am. Chem. Soc. 1987, 109, 7063;
481. c) S. Hanessian, A. Ugolini, P. Hodges, P. Beaulieu, D. Dubé, C. André, Pure Appl. Chem. 1987, 59, 299.
482. For syntheses of the avermectins, see: a) S. Danishefsky, S. J. Armistead, D.-M. Winnot, F. E. Selnick, R. Hungate, J. Am. Chem. Soc. 1989, 111, 2967;
483. b) M. J. Ford, J. G. Knight, S. V. Ley, S. Vile, Synlett 1990, 331;
484. J. D. White, G. L. Bolton, J. Am. Chem. Soc. 1990, 112, 1626.
485. For other observations concerning conjugation and deconjugation in the avermectin series, see: a) J. V. Pivnichny, J.-S. Shim, L. A. Simmerman, J. Pharm. Sci. 1983, 72, 1447;
486. b) B. Fraser-Reid, H. Wolleb, R. Faghih, J. Varchi, Jr., J. Am. Chem. Soc. 1987, 109, 933.
487. S. Hanessian, A. Ugolini, P. J. Hodges, D. Dubé, Tetrahedron Lett. 1986, 27, 2699.
488. S. Hanessian, P. Chemla, Y. Tu, Tetrahedron Lett. 1993, 34, 1407.
489. E. J. Corey, J. W. Ponder, Tetrahedron Lett. 1984, 25, 4325.
490. G. Werner, H. Hagenmaier, H. Drautz, A. Baumgartner, H. Zähner, J. Antibiot. 1984, 37, 110.
491. a) J. R. Everett, G. H. Baker, R. J. J. Dorgan, J. Chem. Soc. Perkin Trans. 2 1990, 717;
492. b) G. H. Baker, P. J. Brown, R. J. J. Dorgan, J. R. Everett, S. V. Ley, A. M. Z. Slawin, D. J. Williams, Tetrahedron Lett. 1987, 28, 5565.
493. a) E. J. Bowman, A. Siebers; K. Altendorf, Proc. Natl. Acad. Sci. USA 1988, 85, 7972;
494. b) for a review see, D. K. Stone, B. P. Crider, T. C. Südhof, X.-S. Xie, J. Bioenerg. Biomembr. 1989, 21, 605.
495. S. Hanessian, J. Ma, W. Wang, Y. Gai, J. Am. Chem. Soc. 2001, 123, 10 200.
496. S. Hanessian, Q. Meng, E. Olivier, Tetrahedron Lett. 1994, 35, 5393.
497. S. Hanessian, A. Tehim, Q. Meng, Tetrahedron Lett. 1996, 37, 9001.
498. a) "Pharma in Flux": R. Mullin, Chem. Eng. News 2006, 84 (June 19), 30;
499. b) "Big Pharma's Commedia": F. R. Steele, Cell 2005, 123, 971.
500. M. McCoy, L. M. Jarvis, Chem. Eng. News 2006, 84 (April 10), 19.